Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.

Fillit HM, Kemeny E, Luine V, Weksler ME, Zabriskie JB.

J Gerontol. 1987 Mar;42(2):180-4.

PMID:
2950160
2.

Alzheimer's disease: the proteoglycans hypothesis.

Celesia GG.

Semin Thromb Hemost. 1991;17 Suppl 2:158-60. Review. No abstract available.

PMID:
1948087
3.
4.

Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus.

Fillit H, Shibata S, Sasaki T, Spiera H, Kerr LD, Blake M.

Autoimmunity. 1993;14(3):243-9.

PMID:
8329561
5.

Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsies.

Kemeny E, Fillit HM, Damle S, Mahabir R, Kefalides NA, Gregory JD, Antonovych T, Sabnis S, Zabriskie JB.

Connect Tissue Res. 1988;18(1):9-25.

PMID:
2972530
7.

Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.

Perlmutter LS, Chui HC, Saperia D, Athanikar J.

Brain Res. 1990 Jan 29;508(1):13-9.

PMID:
2140065
8.

Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.

Buée L, Ding W, Anderson JP, Narindrasorasak S, Kisilevsky R, Boyle NJ, Robakis NK, Delacourte A, Greenberg B, Fillit HM.

Brain Res. 1993 Nov 12;627(2):199-204.

PMID:
8298962
9.

Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.

Shimizu H, Ghazizadeh M, Sato S, Oguro T, Kawanami O.

J Clin Neurosci. 2009 Feb;16(2):277-82. doi: 10.1016/j.jocn.2008.04.009. Epub 2008 Dec 16.

PMID:
19091577
10.

Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.

Levin EC, Acharya NK, Han M, Zavareh SB, Sedeyn JC, Venkataraman V, Nagele RG.

Brain Res. 2010 Jul 23;1345:221-32. doi: 10.1016/j.brainres.2010.05.038. Epub 2010 Jun 11.

PMID:
20546711
12.
13.

Basement membrane heparan sulfate proteoglycan from the L2 rat yolk sac carcinoma.

Fenger M, Wewer U, Albrechtsen R.

FEBS Lett. 1984 Jul 23;173(1):75-9.

14.

[Proteoglycans in senile dementia of Alzheimer's type].

Shimizu H, Sato S, Ohishi H, Mori O, Mori T, Ohami H.

Nihon Ronen Igakkai Zasshi. 1997 Jun;34(6):461-7. Japanese.

15.

Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.

Buée L, Ding W, Delacourte A, Fillit H.

Brain Res. 1993 Jan 22;601(1-2):154-63.

PMID:
8431762
16.

Renal localization of heparan sulfate proteoglycan by immunohistochemistry.

Klein DJ, Oegema TR, Eisenstein R, Furcht L, Michael AF, Brown DM.

Am J Pathol. 1983 Jun;111(3):323-30.

17.

Heparan sulphate proteoglycans from human glomerular and tubular basement membranes are related molecules.

van den Heuvel LP, Veerkamp JH, van den Born J, Monnens LA, Berden JH.

Biochem Soc Trans. 1990 Oct;18(5):960. No abstract available.

PMID:
2083767
18.

Antimicroglia antibodies in sera of Alzheimer's disease patients.

Lemke MR, Glatzel M, Henneberg AE.

Biol Psychiatry. 1999 Feb 15;45(4):508-11.

PMID:
10071725
19.

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.

Snow AD, Kinsella MG, Parks E, Sekiguchi RT, Miller JD, Kimata K, Wight TN.

Arch Biochem Biophys. 1995 Jun 20;320(1):84-95.

PMID:
7793988
20.

Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.

Arepally GM, Kamei S, Park KS, Kamei K, Li ZQ, Liu W, Siegel DL, Kisiel W, Cines DB, Poncz M.

Blood. 2000 Mar 1;95(5):1533-40.

Supplemental Content

Support Center